Epitalon

LongevityPineal tetrapeptide / researchExperimental

Also known as: Epithalon, Epithalamin analog, AEDG, Ala-Glu-Asp-Gly

Epitalon (also called Epithalon or Epithalamin analog) is a pineal tetrapeptide in the Telomerase Activator class. Epitalon is Ala-Glu-Asp-Gly, a synthetic tetrapeptide derived from epithalamin, a pineal extract studied in Soviet gerontology. Two mechanisms are reported. The first is induction of telomerase reverse transcriptase expression, with somatic cell studies describing telomere elongation and extended proliferative capacity — the basis of most interest in the compound.

Calculate Dose

For research use only.

Key Facts

CAS
307297-39-8
Molecular Weight (MW)
390.35 g/mol
Half-life
Short (~10 min)
FDA status
Not Approved
Evidence level
Insufficient Evidence
Human dose established
No
Administration Route
Not established in humans
Frequency
Not established in humans
Last updated
Sep 26, 2026
Reviewed
Aug 30, 2026
Targets
Telomerase (proposed)Pineal / circadian axis

Vendor price snapshot

Each vendor counts once, at the median price per mg of its own listings; the typical range is the middle half of vendors. From public vendor listings collected between Dec 2025 and Sep 2026, so confirm the live price on the vendor site. Peptide Library does not sell peptides.

Vendors listing this peptide
33
Listed offers
43
Median price per mg
$3.50/mg
Typical $2.80–$5.00/mg

Open calculator · Compare vendors

Research summary

Synthetic pineal tetrapeptide (AEDG) from Khavinson’s work on epithalamin. Studied for telomerase and circadian research; not FDA-approved.

Peptide Library's Epitalon profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Epitalon dosage: no established human dose

Epitalon has no established human dosage. No trial of it is registered on ClinicalTrials.gov, and a single human publication is indexed in PubMed — a 2002 report on retinal condition in retinitis pigmentosa, from the Russian group that developed the compound. The longevity and telomerase claims it is sold on have no registered trial and no independent human replication.

Insufficient Evidence

No established human dosage.

Human clinical evidence: None identified.

Preclinical research: Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin, developed at the St Petersburg Institute of Bioregulation and Gerontology. The supporting literature is dominated by that institute's own rodent lifespan and pineal-function work. Independent replication is scarce, no trial is registered internationally, and a single indexed human publication reports no dose. Nothing here establishes a human dose, route or interval.

Animal dosing is not converted into a human dose anywhere on this page. Where research figures appear below, they are reported as studied, not recommended.

Dosage evidence summary for Epitalon
Human dosing establishedNo
RouteNot established in humans
Evidence levelInsufficient Evidence
Last reviewed2026-09-05

Human research reported

Doses as studied, one row per regimen. Different trials used different regimens; they are listed separately rather than averaged.

Research-reported dosing for Epitalon, one row per studied regimen
Study / contextPopulationDoseRouteFrequencyDurationOutcome studiedSource
Retinitis pigmentosa report (2002)Clinical trial · Clinical report from the originating research groupPatients with retinitis pigmentosaNot stated in the indexed recordNot stated in the indexed record——Eye retina conditionPineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuro Endocrinol Lett. 2002.

Where sources disagree

  • Protocols of 5–10 mg daily for 10–20 day courses are widely published for epitalon. No registered trial and no indexed human study reports any dose, and no primary source for those figures could be identified.
  • Epitalon is frequently described as a telomerase activator that extends lifespan. Those claims originate in rodent studies and cell work from the group that developed the compound; there is no human outcome trial testing them.
  • Epithalamin, the pineal extract, and epitalon, the synthetic tetrapeptide, are distinct and are often conflated in secondary sources. Evidence generated with the extract is not dosing evidence for the peptide.

Reconstitution

Common research vial sizes: 10 mg, 50 mg.

Reconstitution arithmetic for Epitalon
VialBacteriostatic waterConcentrationPer 0.01 mL
10 mg2 mL5 mg/mL50 mcg per 0.01 mL
50 mg5 mL10 mg/mL100 mcg per 0.01 mL

These figures are arithmetic only — they convert a vial and a volume into a concentration. They are not a recommendation to take any dose.

Calculate reconstitution & dose →

Handling & administration

Reconstitution Guide
2 mL BAC for 50 mg vial
Injection Sites
Abdomen
Concentration Example
50 mg / 2 mL = 25 mg/mL
Timing Notes
Evening
Expected Onset
Days for sleep, months for telomere

How to reconstitute Epitalon

  1. Check the vial size and diluent volume. The profile example for Epitalon is: 2 mL BAC for 50 mg vial.
  2. Swab both vial stoppers and draw the bacteriostatic water into a sterile syringe.
  3. Add the water slowly down the inside wall of the peptide vial so it does not jet onto the powder, then swirl gently until the solution is clear. Do not shake.
  4. Record the resulting concentration: 50 mg / 2 mL = 25 mg/mL.
  5. Label the vial with the date and concentration, refrigerate it (see Storage & stability below), and use the calculator preset to convert a dose in mcg into syringe units.

Open the peptide calculator with the Epitalon preset →

Sequence & molecular data

Sequence and molecular data for Epitalon
Amino acid sequenceAla-Glu-Asp-Gly
Molecular formulaC14H22N4O9
Molecular weight390.35 g/mol
CAS number307297-39-8
Half-lifeShort (~10 min)
AppearanceWhite lyophilized powder
FormulationLyophilized Powder
PubChem CID219042
FDA UNIIO65P17785G

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

Epitalon is Ala-Glu-Asp-Gly, a synthetic tetrapeptide derived from epithalamin, a pineal extract studied in Soviet gerontology. Two mechanisms are reported. The first is induction of telomerase reverse transcriptase expression, with somatic cell studies describing telomere elongation and extended proliferative capacity — the basis of most interest in the compound. The second is normalisation of the melatonin secretion rhythm, consistent with its pineal origin. Rodent studies from the originating group report increased lifespan and reduced tumour incidence. The findings have not been replicated in independent Western laboratories or confirmed in controlled human trials, and induction of telomerase is not an unambiguously desirable effect given its role in tumour cell immortalisation.

Origin

Synthetic Ala-Glu-Asp-Gly.

Targets

Telomerase (proposed)Pineal / circadian axis

Regulatory & research status

Epitalon is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

Regulatory and research status for Epitalon
FDA statusNot Approved
AvailabilityResearch-Only
WADA (sport)Unknown / Not Listed
Library classificationResearch-Only

Benefits

Telomere supportSleep improvementAnti-aging

Epitalon side effects

Epitalon has no controlled human safety data. The effects below are reported, not established, and absence from the list is not evidence of safety.

Side Effects

  • Mild injection reactions

Contraindications

  • Cancer history

Stacking

Common stacking partners

Combinations that include Epitalon, with the proposed rationale, an evidence grade and what is not established, are catalogued in the peptide stacks directory.

Storage & stability

Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.

Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freeze–thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.

Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.

Read the full guide: how to store peptides before and after reconstitution →

Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. (PMID 20143256). General guidance for research handling; not product-specific instructions.

Epitalon: frequently asked questions

What is Epitalon?

Synthetic pineal tetrapeptide (AEDG) from Khavinson’s work on epithalamin. Studied for telomerase and circadian research; not FDA-approved. Epitalon is Ala-Glu-Asp-Gly, a synthetic tetrapeptide derived from epithalamin, a pineal extract studied in Soviet gerontology. Two mechanisms are reported. The first is induction of telomerase reverse transcriptase expression, with somatic cell studies describing telomere elongation and extended proliferative capacity — the basis of most interest in the compound.

What are the side effects of Epitalon?

Epitalon has no controlled human safety data, so its side-effect profile is not well established. Effects recorded on this profile include mild injection reactions. Cautions recorded on this profile: cancer history. This is reference information, not medical advice.

How does Epitalon work?

Epitalon is Ala-Glu-Asp-Gly, a synthetic tetrapeptide derived from epithalamin, a pineal extract studied in Soviet gerontology. Two mechanisms are reported.

Is Epitalon FDA approved?

No. Epitalon is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

What is the half-life of Epitalon?

Reported half-life for Epitalon is Short (~10 min). Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

What is the amino acid sequence of Epitalon?

Epitalon has the sequence Ala-Glu-Asp-Gly, giving a chain of 4 amino acids. Its molecular formula is C14H22N4O9.

What peptides are similar to Epitalon?

Compounds most often compared with Epitalon include Pinealon, Klotho, FOXO4-DRI and NAD+ (Nicotinamide Adenine Dinucleotide). They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

How long does Epitalon take to show effects in research protocols?

The research protocol on this profile lists an expected onset of days for sleep, months for telomere. This is a protocol note describing when studies and researchers report observing changes, not a measured clinical outcome, and it varies with the model, dose and endpoint studied.

Where is Epitalon administered in research protocols?

Research protocols on this profile use subcutaneous administration, with recorded sites including abdomen. Site rotation and sterile technique are standard practice in the research literature; this describes protocol conditions and is not guidance for use.

Does epitalon lengthen telomeres in humans?

Not on current evidence. Cell-culture work reports increased telomerase activity and animal studies report lifespan effects, but no adequately powered, independently replicated human trial shows telomere lengthening. The human evidence is observational, from elderly cohorts, and comes largely from a single Russian research tradition published mostly in Russian-language journals.

Is epitalon the same as epithalamin?

Related, not identical. Epithalamin is the original peptide extract from the pineal gland; epitalon (Ala-Glu-Asp-Gly) is the synthetic four-amino-acid peptide developed from work on it.

Is activating telomerase a good thing?

Not self-evidently. Most body cells suppress telomerase, and cancer cells typically reactivate it to keep dividing, so that suppression is generally seen as a tumour-suppressing mechanism. No evidence shows epitalon causes cancer, but a compound claiming telomerase activation warrants more scrutiny rather than less, which is why cancer history is listed as a caution on this profile.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial · Reviewed Aug 30, 2026 · Updated Sep 26, 2026 · Version 6

This Epitalon profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy · How profiles are compiled · Report an error

Track Epitalon research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android →